Literature DB >> 20842397

Retrospective study on PET-SPECT imaging in a large cohort of myotonic dystrophy type 1 patients.

Vincenzo Romeo1, E Pegoraro, F Squarzanti, G Sorarù, C Ferrati, M Ermani, P Zucchetta, F Chierichetti, C Angelini.   

Abstract

The aim was to study brain involvement in myotonic dystrophy type 1 by single photon emission tomography (SPECT) and positron emission tomography (PET). 58 DM1 patients were subjected to SPECT; 17 to both SPECT and PET. SPECT patients were grouped as 'normally perfused' and 'abnormally perfused'; PET patients as 'normal performers' and 'abnormal performers'. To quantify hypoperfusion and/or hypometabolism, we used a semi-quantitative scale. To localize focal hypoperfusion/hypometabolism, nine cerebral areas of involvement were identified. The Chi-square, Wilcoxon, McNemar tests were used for statistics. SPECT showed abnormalities in 52/58 patients. PET showed an abnormal glucidic uptake in 15/17. Hypoperfusion was mild/moderate in 50/58 patients, mostly involving the left supratentorial areas. Abnormal glucidic uptake was mainly observed in the left frontal lobe. Abnormalities in blood perfusion and/or glucose metabolism are frequent in DM1. These abnormalities involve the left more often than the right hemisphere, the frontal lobe more than other lobes. Such abnormalities are more often cortical than subcortical.

Entities:  

Mesh:

Year:  2010        PMID: 20842397     DOI: 10.1007/s10072-010-0406-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  33 in total

1.  Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy.

Authors:  G Meola; V Sansone; D Perani; A Colleluori; S Cappa; M Cotelli; F Fazio; C A Thornton; R T Moxley
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

2.  Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities.

Authors:  Antonio Giorgio; Maria T Dotti; Marco Battaglini; Silvia Marino; Marzia Mortilla; Maria L Stromillo; Placido Bramanti; Alfredo Orrico; Antonio Federico; Nicola De Stefano
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

3.  Anterior temporal white matter lesions in myotonic dystrophy with intellectual impairment: an MRI and neuropathological study.

Authors:  A Ogata; S Terae; M Fujita; K Tashiro
Journal:  Neuroradiology       Date:  1998-07       Impact factor: 2.804

4.  Brain MRI features of congenital- and adult-form myotonic dystrophy type 1: case-control study.

Authors:  Alfonso Di Costanzo; Francesco Di Salle; Lucio Santoro; Vincenzo Bonavita; Gioacchino Tedeschi
Journal:  Neuromuscul Disord       Date:  2002-06       Impact factor: 4.296

5.  Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats.

Authors:  L Chang; T Ernst; D Osborn; W Seltzer; M Leonido-Yee; R E Poland
Journal:  Arch Neurol       Date:  1998-03

6.  White matter lesions and cognitive deficits: relevance of lesion pattern?

Authors:  M S Damian; G Schilling; G Bachmann; C Simon; S Stöppler; W Dorndorf
Journal:  Acta Neurol Scand       Date:  1994-12       Impact factor: 3.209

7.  Neuroimaging study of myotonic dystrophy. I. Magnetic resonance imaging of the brain.

Authors:  T Hashimoto; M Tayama; M Miyazaki; K Murakawa; H Kawai; H Nishitani; Y Kuroda
Journal:  Brain Dev       Date:  1995 Jan-Feb       Impact factor: 1.961

8.  Cognitive impairment and (CTG)n expansion in myotonic dystrophy patients.

Authors:  G I Perini; E Menegazzo; M Ermani; M Zara; A Gemma; E Ferruzza; M Gennarelli; C Angelini
Journal:  Biol Psychiatry       Date:  1999-08-01       Impact factor: 13.382

9.  Epidemiology of myotonic dystrophy in Italy: re-apprisal after genetic diagnosis.

Authors:  G Siciliano; M Manca; M Gennarelli; C Angelini; A Rocchi; A Iudice; M Miorin; M Mostacciuolo
Journal:  Clin Genet       Date:  2001-05       Impact factor: 4.438

10.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.

Authors:  K L Taneja; M McCurrach; M Schalling; D Housman; R H Singer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  12 in total

1.  Myotonic dystrophies as a brain disorder.

Authors:  Giovanni Meola
Journal:  Neurol Sci       Date:  2010-10-06       Impact factor: 3.307

2.  Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression.

Authors:  Carla Ramon-Duaso; Thomas Gener; Marta Consegal; Cristina Fernández-Avilés; Juan José Gallego; Laura Castarlenas; Maurice S Swanson; Rafael de la Torre; Rafael Maldonado; M Victoria Puig; Patricia Robledo
Journal:  Cereb Cortex       Date:  2019-07-05       Impact factor: 5.357

3.  A GEE Approach to Determine Sample Size for Pre- and Post-Intervention Experiments with Dropout.

Authors:  Song Zhang; Jing Cao; Chul Ahn
Journal:  Comput Stat Data Anal       Date:  2014-01       Impact factor: 1.681

4.  Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour.

Authors:  Oscar Hernández-Hernández; Céline Guiraud-Dogan; Géraldine Sicot; Aline Huguet; Sabrina Luilier; Esther Steidl; Stefanie Saenger; Elodie Marciniak; Hélène Obriot; Caroline Chevarin; Annie Nicole; Lucile Revillod; Konstantinos Charizanis; Kuang-Yung Lee; Yasuhiro Suzuki; Takashi Kimura; Tohru Matsuura; Bulmaro Cisneros; Maurice S Swanson; Fabrice Trovero; Bruno Buisson; Jean-Charles Bizot; Michel Hamon; Sandrine Humez; Guillaume Bassez; Friedrich Metzger; Luc Buée; Arnold Munnich; Nicolas Sergeant; Geneviève Gourdon; Mário Gomes-Pereira
Journal:  Brain       Date:  2013-02-11       Impact factor: 13.501

5.  Sample size calculation for before-after experiments with partially overlapping cohorts.

Authors:  Song Zhang; Jing Cao; Chul Ahn
Journal:  Contemp Clin Trials       Date:  2015-09-28       Impact factor: 2.226

6.  In myotonic dystrophy type 1 reduced FDG-uptake on FDG-PET is most severe in Brodmann area 8.

Authors:  Dimitri Renard; Laurent Collombier; Christel Castelli; Jean-Pierre Pouget; Pierre-Olivier Kotzki; Vincent Boudousq
Journal:  BMC Neurol       Date:  2016-07-13       Impact factor: 2.474

7.  Brain gray matter structural network in myotonic dystrophy type 1.

Authors:  Atsuhiko Sugiyama; Daichi Sone; Noriko Sato; Yukio Kimura; Miho Ota; Norihide Maikusa; Tomoko Maekawa; Mikako Enokizono; Madoka Mori-Yoshimura; Yasushi Ohya; Satoshi Kuwabara; Hiroshi Matsuda
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 8.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

9.  Synaptic protein dysregulation in myotonic dystrophy type 1: Disease neuropathogenesis beyond missplicing.

Authors:  Oscar Hernández-Hernández; Géraldine Sicot; Diana M Dinca; Aline Huguet; Annie Nicole; Luc Buée; Arnold Munnich; Nicolas Sergeant; Geneviève Gourdon; Mário Gomes-Pereira
Journal:  Rare Dis       Date:  2013-06-26

Review 10.  Current Progress in CNS Imaging of Myotonic Dystrophy.

Authors:  Martina Minnerop; Carla Gliem; Cornelia Kornblum
Journal:  Front Neurol       Date:  2018-08-21       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.